カテゴリ： QYResearch, 世界, 医療/バイオ

ジピン系降圧剤の世界市場2025年：ニフェジピン、アムロジピンベシル酸塩、フェリジピン、ベニジピン、その他

■ 英語タイトル：Global Dipine Antihypertensive Drugs Market Research Report 2025

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8740）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8740
■ 発行日：2025年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥417,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥626,400見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥835,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ジピン系降圧剤の世界市場2025年：ニフェジピン、アムロジピンベシル酸塩、フェリジピン、ベニジピン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はジピン系降圧剤のグローバル市場について調査・分析し、世界のジピン系降圧剤市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（ニフェジピン、アムロジピンベシル酸塩、フェリジピン、ベニジピン、その他）、用途別セグメント分析（病院、クリニック）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Johnson & Johnson、Merck & Co., Inc.、NOVARTIS、Astrazeneca、Bayer、Kyowa Hakko Kogyo、Zuventus Health care ltd、JB Chemicals and Pharmaceuticals Ltd、Boehringer Ingelheim、GSK、Daiichi-Sankyo、fujipharmaなどが含まれています。ジピン系降圧剤のグローバル市場は、2024年にXXX米ドル、2031年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。貿易戦争とロシア・ウクライナ戦争の影響は、ジピン系降圧剤市場規模を算出する際に考慮しました。

・ジピン系降圧剤市場の概要
- 製品の定義
- ジピン系降圧剤の種類別セグメント
- 世界のジピン系降圧剤市場規模：タイプ別分析（ニフェジピン、アムロジピンベシル酸塩、フェリジピン、ベニジピン、その他）
- ジピン系降圧剤の用途別セグメント
- 世界のジピン系降圧剤市場規模：用途別分析（病院、クリニック）
- 世界のジピン系降圧剤市場規模予測（2020年-2031年）
- ジピン系降圧剤の平均価格推移（2020年-2031年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- ジピン系降圧剤市場の競争状況およびトレンド

・ジピン系降圧剤の地域別市場規模
- 北米のジピン系降圧剤市場規模（2020年-2031年）
- 米国のジピン系降圧剤市場規模（2020年-2031年）
- ヨーロッパのジピン系降圧剤市場規模（2020年-2031年）
- アジア太平洋のジピン系降圧剤市場規模（2020年-2031年）
- 中国のジピン系降圧剤市場規模（2020年-2031年）
- 日本のジピン系降圧剤市場規模（2020年-2031年）
- 韓国のジピン系降圧剤市場規模（2020年-2031年）
- インドのジピン系降圧剤市場規模（2020年-2031年）
- オーストラリアのジピン系降圧剤市場規模（2020年-2031年）
- 中南米のジピン系降圧剤市場規模（2020年-2031年）
- 中東・アフリカのジピン系降圧剤市場規模（2020年-2031年）

・種類別セグメント：ニフェジピン、アムロジピンベシル酸塩、フェリジピン、ベニジピン、その他
- 世界のジピン系降圧剤のタイプ別販売量（2020年-2025年）
- 世界のジピン系降圧剤のタイプ別売上（2020年-2025年）
- 世界のジピン系降圧剤のタイプ別価格

・用途別セグメント：病院、クリニック
- 世界のジピン系降圧剤の用途別販売量（2020年-2025年）
- 世界のジピン系降圧剤の用途別売上（2020年-2025年）
- 世界のジピン系降圧剤の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Johnson & Johnson、Merck & Co., Inc.、NOVARTIS、Astrazeneca、Bayer、Kyowa Hakko Kogyo、Zuventus Health care ltd、JB Chemicals and Pharmaceuticals Ltd、Boehringer Ingelheim、GSK、Daiichi-Sankyo、fujipharma

・産業チェーンと販売チャネルの分析
- ジピン系降圧剤産業チェーン分析
- ジピン系降圧剤の主要原材料
- ジピン系降圧剤の販売チャネル
- ジピン系降圧剤のディストリビューター
- ジピン系降圧剤の主要顧客

・ジピン系降圧剤市場ダイナミクス
- ジピン系降圧剤の業界動向
- ジピン系降圧剤市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Highlights
The global Dipine Antihypertensive Drugs market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of % during the forecast period 2025-2031. The influence of trade war and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Dipine Antihypertensive Drugs is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dipine Antihypertensive Drugs is estimated to increase from $ million in 2023 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The key global manufacturers of Dipine Antihypertensive Drugs include Johnson & Johnson, Merck & Co., Inc., NOVARTIS, Astrazeneca, Bayer, Kyowa Hakko Kogyo, Zuventus Health care ltd, JB Chemicals and Pharmaceuticals Ltd and Boehringer Ingelheim, etc. in 2024, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dipine Antihypertensive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dipine Antihypertensive Drugs.
The Dipine Antihypertensive Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dipine Antihypertensive Drugs market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dipine Antihypertensive Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Johnson & Johnson
Merck & Co., Inc.
NOVARTIS
Astrazeneca
Bayer
Kyowa Hakko Kogyo
Zuventus Health care ltd
JB Chemicals and Pharmaceuticals Ltd
Boehringer Ingelheim
GSK
Daiichi-Sankyo
fujipharma
Segment by Type
Nifedipine
Amlodipine Besylate
Felidipine
Benidipine
Other
Segment by Application
Hospital
Clinic
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dipine Antihypertensive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dipine Antihypertensive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Dipine Antihypertensive Drugs Market Overview
1.1 Product Overview and Scope of Dipine Antihypertensive Drugs
1.2 Dipine Antihypertensive Drugs Segment by Type
1.2.1 Global Dipine Antihypertensive Drugs Market Value Comparison by Type (2025-2031)
1.2.2 Nifedipine
1.2.3 Amlodipine Besylate
1.2.4 Felidipine
1.2.5 Benidipine
1.2.6 Other
1.3 Dipine Antihypertensive Drugs Segment by Application
1.3.1 Global Dipine Antihypertensive Drugs Market Value by Application: (2025-2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Dipine Antihypertensive Drugs Market Size Estimates and Forecasts
1.4.1 Global Dipine Antihypertensive Drugs Revenue 2020-2031
1.4.2 Global Dipine Antihypertensive Drugs Sales 2020-2031
1.4.3 Global Dipine Antihypertensive Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Dipine Antihypertensive Drugs Market Competition by Manufacturers
2.1 Global Dipine Antihypertensive Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Dipine Antihypertensive Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Dipine Antihypertensive Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Dipine Antihypertensive Drugs Industry Ranking 2023 VS 2024 VS 2025
2.5 Global Key Manufacturers of Dipine Antihypertensive Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dipine Antihypertensive Drugs, Product Type & Application
2.7 Dipine Antihypertensive Drugs Market Competitive Situation and Trends
2.7.1 Dipine Antihypertensive Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dipine Antihypertensive Drugs Players Market Share by Revenue
2.7.3 Global Dipine Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dipine Antihypertensive Drugs Retrospective Market Scenario by Region
3.1 Global Dipine Antihypertensive Drugs Market Size by Region: 2020 Versus 2024 Versus 2025
3.2 Global Dipine Antihypertensive Drugs Global Dipine Antihypertensive Drugs Sales by Region: 2020-2031
3.2.1 Global Dipine Antihypertensive Drugs Sales by Region: 2020-2025
3.2.2 Global Dipine Antihypertensive Drugs Sales by Region: 2026-2031
3.3 Global Dipine Antihypertensive Drugs Global Dipine Antihypertensive Drugs Revenue by Region: 2020-2031
3.3.1 Global Dipine Antihypertensive Drugs Revenue by Region: 2020-2025
3.3.2 Global Dipine Antihypertensive Drugs Revenue by Region: 2026-2031
3.4 North America Dipine Antihypertensive Drugs Market Facts & Figures by Country
3.4.1 North America Dipine Antihypertensive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Dipine Antihypertensive Drugs Sales by Country (2020-2031)
3.4.3 North America Dipine Antihypertensive Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dipine Antihypertensive Drugs Market Facts & Figures by Country
3.5.1 Europe Dipine Antihypertensive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Dipine Antihypertensive Drugs Sales by Country (2020-2031)
3.5.3 Europe Dipine Antihypertensive Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dipine Antihypertensive Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Dipine Antihypertensive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Dipine Antihypertensive Drugs Sales by Country (2020-2031)
3.6.3 Asia Pacific Dipine Antihypertensive Drugs Revenue by Country (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Dipine Antihypertensive Drugs Market Facts & Figures by Country
3.7.1 Latin America Dipine Antihypertensive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Dipine Antihypertensive Drugs Sales by Country (2020-2031)
3.7.3 Latin America Dipine Antihypertensive Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dipine Antihypertensive Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Dipine Antihypertensive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Dipine Antihypertensive Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Dipine Antihypertensive Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dipine Antihypertensive Drugs Sales by Type (2020-2031)
4.1.1 Global Dipine Antihypertensive Drugs Sales by Type (2020-2025)
4.1.2 Global Dipine Antihypertensive Drugs Sales by Type (2026-2031)
4.1.3 Global Dipine Antihypertensive Drugs Sales Market Share by Type (2020-2031)
4.2 Global Dipine Antihypertensive Drugs Revenue by Type (2020-2031)
4.2.1 Global Dipine Antihypertensive Drugs Revenue by Type (2020-2025)
4.2.2 Global Dipine Antihypertensive Drugs Revenue by Type (2026-2031)
4.2.3 Global Dipine Antihypertensive Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Dipine Antihypertensive Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Dipine Antihypertensive Drugs Sales by Application (2020-2031)
5.1.1 Global Dipine Antihypertensive Drugs Sales by Application (2020-2025)
5.1.2 Global Dipine Antihypertensive Drugs Sales by Application (2026-2031)
5.1.3 Global Dipine Antihypertensive Drugs Sales Market Share by Application (2020-2031)
5.2 Global Dipine Antihypertensive Drugs Revenue by Application (2020-2031)
5.2.1 Global Dipine Antihypertensive Drugs Revenue by Application (2020-2025)
5.2.2 Global Dipine Antihypertensive Drugs Revenue by Application (2026-2031)
5.2.3 Global Dipine Antihypertensive Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Dipine Antihypertensive Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Dipine Antihypertensive Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Corporation Information
6.2.2 Merck & Co., Inc. Description and Business Overview
6.2.3 Merck & Co., Inc. Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck & Co., Inc. Dipine Antihypertensive Drugs Product Portfolio
6.2.5 Merck & Co., Inc. Recent Developments/Updates
6.3 NOVARTIS
6.3.1 NOVARTIS Corporation Information
6.3.2 NOVARTIS Description and Business Overview
6.3.3 NOVARTIS Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 NOVARTIS Dipine Antihypertensive Drugs Product Portfolio
6.3.5 NOVARTIS Recent Developments/Updates
6.4 Astrazeneca
6.4.1 Astrazeneca Corporation Information
6.4.2 Astrazeneca Description and Business Overview
6.4.3 Astrazeneca Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Astrazeneca Dipine Antihypertensive Drugs Product Portfolio
6.4.5 Astrazeneca Recent Developments/Updates
6.5 Bayer
6.5.1 Bayer Corporation Information
6.5.2 Bayer Description and Business Overview
6.5.3 Bayer Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bayer Dipine Antihypertensive Drugs Product Portfolio
6.5.5 Bayer Recent Developments/Updates
6.6 Kyowa Hakko Kogyo
6.6.1 Kyowa Hakko Kogyo Corporation Information
6.6.2 Kyowa Hakko Kogyo Description and Business Overview
6.6.3 Kyowa Hakko Kogyo Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kyowa Hakko Kogyo Dipine Antihypertensive Drugs Product Portfolio
6.6.5 Kyowa Hakko Kogyo Recent Developments/Updates
6.7 Zuventus Health care ltd
6.6.1 Zuventus Health care ltd Corporation Information
6.6.2 Zuventus Health care ltd Description and Business Overview
6.6.3 Zuventus Health care ltd Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zuventus Health care ltd Dipine Antihypertensive Drugs Product Portfolio
6.7.5 Zuventus Health care ltd Recent Developments/Updates
6.8 JB Chemicals and Pharmaceuticals Ltd
6.8.1 JB Chemicals and Pharmaceuticals Ltd Corporation Information
6.8.2 JB Chemicals and Pharmaceuticals Ltd Description and Business Overview
6.8.3 JB Chemicals and Pharmaceuticals Ltd Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 JB Chemicals and Pharmaceuticals Ltd Dipine Antihypertensive Drugs Product Portfolio
6.8.5 JB Chemicals and Pharmaceuticals Ltd Recent Developments/Updates
6.9 Boehringer Ingelheim
6.9.1 Boehringer Ingelheim Corporation Information
6.9.2 Boehringer Ingelheim Description and Business Overview
6.9.3 Boehringer Ingelheim Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Boehringer Ingelheim Dipine Antihypertensive Drugs Product Portfolio
6.9.5 Boehringer Ingelheim Recent Developments/Updates
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK Dipine Antihypertensive Drugs Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Daiichi-Sankyo
6.11.1 Daiichi-Sankyo Corporation Information
6.11.2 Daiichi-Sankyo Dipine Antihypertensive Drugs Description and Business Overview
6.11.3 Daiichi-Sankyo Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Daiichi-Sankyo Dipine Antihypertensive Drugs Product Portfolio
6.11.5 Daiichi-Sankyo Recent Developments/Updates
6.12 fujipharma
6.12.1 fujipharma Corporation Information
6.12.2 fujipharma Dipine Antihypertensive Drugs Description and Business Overview
6.12.3 fujipharma Dipine Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 fujipharma Dipine Antihypertensive Drugs Product Portfolio
6.12.5 fujipharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dipine Antihypertensive Drugs Industry Chain Analysis
7.2 Dipine Antihypertensive Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dipine Antihypertensive Drugs Production Mode & Process
7.4 Dipine Antihypertensive Drugs Sales and Marketing
7.4.1 Dipine Antihypertensive Drugs Sales Channels
7.4.2 Dipine Antihypertensive Drugs Distributors
7.5 Dipine Antihypertensive Drugs Customers
8 Dipine Antihypertensive Drugs Market Dynamics
8.1 Dipine Antihypertensive Drugs Industry Trends
8.2 Dipine Antihypertensive Drugs Market Drivers
8.3 Dipine Antihypertensive Drugs Market Challenges
8.4 Dipine Antihypertensive Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Dipine Antihypertensive Drugs Market Value Comparison by Type (2025-2031) & (US$ Million)
Table 2. Global Dipine Antihypertensive Drugs Market Value Comparison by Application (2025-2031) & (US$ Million)
Table 3. Global Dipine Antihypertensive Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global Dipine Antihypertensive Drugs Sales (Units) of Key Manufacturers (2020-2025)
Table 5. Global Dipine Antihypertensive Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Dipine Antihypertensive Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Dipine Antihypertensive Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Dipine Antihypertensive Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Dipine Antihypertensive Drugs, Industry Ranking, 2023 VS 2024 VS 2025
Table 10. Global Key Manufacturers of Dipine Antihypertensive Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dipine Antihypertensive Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Dipine Antihypertensive Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dipine Antihypertensive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipine Antihypertensive Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dipine Antihypertensive Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Dipine Antihypertensive Drugs Sales by Region (2020-2025) & (Units)
Table 18. Global Dipine Antihypertensive Drugs Sales Market Share by Region (2020-2025)
Table 19. Global Dipine Antihypertensive Drugs Sales by Region (2026-2031) & (Units)
Table 20. Global Dipine Antihypertensive Drugs Sales Market Share by Region (2026-2031)
Table 21. Global Dipine Antihypertensive Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Dipine Antihypertensive Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global Dipine Antihypertensive Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Dipine Antihypertensive Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America Dipine Antihypertensive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Dipine Antihypertensive Drugs Sales by Country (2020-2025) & (Units)
Table 27. North America Dipine Antihypertensive Drugs Sales by Country (2026-2031) & (Units)
Table 28. North America Dipine Antihypertensive Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Dipine Antihypertensive Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Dipine Antihypertensive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Dipine Antihypertensive Drugs Sales by Country (2020-2025) & (Units)
Table 32. Europe Dipine Antihypertensive Drugs Sales by Country (2026-2031) & (Units)
Table 33. Europe Dipine Antihypertensive Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Dipine Antihypertensive Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Dipine Antihypertensive Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Dipine Antihypertensive Drugs Sales by Region (2020-2025) & (Units)
Table 37. Asia Pacific Dipine Antihypertensive Drugs Sales by Region (2026-2031) & (Units)
Table 38. Asia Pacific Dipine Antihypertensive Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Dipine Antihypertensive Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Dipine Antihypertensive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Dipine Antihypertensive Drugs Sales by Country (2020-2025) & (Units)
Table 42. Latin America Dipine Antihypertensive Drugs Sales by Country (2026-2031) & (Units)
Table 43. Latin America Dipine Antihypertensive Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Dipine Antihypertensive Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Dipine Antihypertensive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East & Africa Dipine Antihypertensive Drugs Sales by Country (2020-2025) & (Units)
Table 47. Middle East & Africa Dipine Antihypertensive Drugs Sales by Country (2026-2031) & (Units)
Table 48. Middle East & Africa Dipine Antihypertensive Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Dipine Antihypertensive Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Dipine Antihypertensive Drugs Sales (Units) by Type (2020-2025)
Table 51. Global Dipine Antihypertensive Drugs Sales (Units) by Type (2026-2031)
Table 52. Global Dipine Antihypertensive Drugs Sales Market Share by Type (2020-2025)
Table 53. Global Dipine Antihypertensive Drugs Sales Market Share by Type (2026-2031)
Table 54. Global Dipine Antihypertensive Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Dipine Antihypertensive Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Dipine Antihypertensive Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global Dipine Antihypertensive Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global Dipine Antihypertensive Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global Dipine Antihypertensive Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global Dipine Antihypertensive Drugs Sales (Units) by Application (2020-2025)
Table 61. Global Dipine Antihypertensive Drugs Sales (Units) by Application (2026-2031)
Table 62. Global Dipine Antihypertensive Drugs Sales Market Share by Application (2020-2025)
Table 63. Global Dipine Antihypertensive Drugs Sales Market Share by Application (2026-2031)
Table 64. Global Dipine Antihypertensive Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Dipine Antihypertensive Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Dipine Antihypertensive Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global Dipine Antihypertensive Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global Dipine Antihypertensive Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global Dipine Antihypertensive Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Johnson & Johnson Dipine Antihypertensive Drugs Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Merck & Co., Inc. Corporation Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck & Co., Inc. Dipine Antihypertensive Drugs Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. NOVARTIS Corporation Information
Table 81. NOVARTIS Description and Business Overview
Table 82. NOVARTIS Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. NOVARTIS Dipine Antihypertensive Drugs Product
Table 84. NOVARTIS Recent Developments/Updates
Table 85. Astrazeneca Corporation Information
Table 86. Astrazeneca Description and Business Overview
Table 87. Astrazeneca Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Astrazeneca Dipine Antihypertensive Drugs Product
Table 89. Astrazeneca Recent Developments/Updates
Table 90. Bayer Corporation Information
Table 91. Bayer Description and Business Overview
Table 92. Bayer Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Bayer Dipine Antihypertensive Drugs Product
Table 94. Bayer Recent Developments/Updates
Table 95. Kyowa Hakko Kogyo Corporation Information
Table 96. Kyowa Hakko Kogyo Description and Business Overview
Table 97. Kyowa Hakko Kogyo Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Kyowa Hakko Kogyo Dipine Antihypertensive Drugs Product
Table 99. Kyowa Hakko Kogyo Recent Developments/Updates
Table 100. Zuventus Health care ltd Corporation Information
Table 101. Zuventus Health care ltd Description and Business Overview
Table 102. Zuventus Health care ltd Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Zuventus Health care ltd Dipine Antihypertensive Drugs Product
Table 104. Zuventus Health care ltd Recent Developments/Updates
Table 105. JB Chemicals and Pharmaceuticals Ltd Corporation Information
Table 106. JB Chemicals and Pharmaceuticals Ltd Description and Business Overview
Table 107. JB Chemicals and Pharmaceuticals Ltd Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. JB Chemicals and Pharmaceuticals Ltd Dipine Antihypertensive Drugs Product
Table 109. JB Chemicals and Pharmaceuticals Ltd Recent Developments/Updates
Table 110. Boehringer Ingelheim Corporation Information
Table 111. Boehringer Ingelheim Description and Business Overview
Table 112. Boehringer Ingelheim Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Boehringer Ingelheim Dipine Antihypertensive Drugs Product
Table 114. Boehringer Ingelheim Recent Developments/Updates
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. GSK Dipine Antihypertensive Drugs Product
Table 119. GSK Recent Developments/Updates
Table 120. Daiichi-Sankyo Corporation Information
Table 121. Daiichi-Sankyo Description and Business Overview
Table 122. Daiichi-Sankyo Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Daiichi-Sankyo Dipine Antihypertensive Drugs Product
Table 124. Daiichi-Sankyo Recent Developments/Updates
Table 125. fujipharma Corporation Information
Table 126. fujipharma Description and Business Overview
Table 127. fujipharma Dipine Antihypertensive Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. fujipharma Dipine Antihypertensive Drugs Product
Table 129. fujipharma Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Dipine Antihypertensive Drugs Distributors List
Table 133. Dipine Antihypertensive Drugs Customers List
Table 134. Dipine Antihypertensive Drugs Market Trends
Table 135. Dipine Antihypertensive Drugs Market Drivers
Table 136. Dipine Antihypertensive Drugs Market Challenges
Table 137. Dipine Antihypertensive Drugs Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dipine Antihypertensive Drugs
Figure 2. Global Dipine Antihypertensive Drugs Market Value Comparison by Type (2025-2031) & (US$ Million)
Figure 3. Global Dipine Antihypertensive Drugs Market Share by Type in 2024 & 2031
Figure 4. Nifedipine Product Picture
Figure 5. Amlodipine Besylate Product Picture
Figure 6. Felidipine Product Picture
Figure 7. Benidipine Product Picture
Figure 8. Other Product Picture
Figure 9. Global Dipine Antihypertensive Drugs Market Value Comparison by Application (2025-2031) & (US$ Million)
Figure 10. Global Dipine Antihypertensive Drugs Market Share by Application in 2024 & 2031
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Global Dipine Antihypertensive Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Dipine Antihypertensive Drugs Market Size (2020-2031) & (US$ Million)
Figure 15. Global Dipine Antihypertensive Drugs Sales (2020-2031) & (Units)
Figure 16. Global Dipine Antihypertensive Drugs Average Price (US$/Unit) & (2020-2031)
Figure 17. Dipine Antihypertensive Drugs Report Years Considered
Figure 18. Dipine Antihypertensive Drugs Sales Share by Manufacturers in 2024
Figure 19. Global Dipine Antihypertensive Drugs Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest Dipine Antihypertensive Drugs Players: Market Share by Revenue in 2024
Figure 21. Dipine Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2020 VS 2024
Figure 22. Global Dipine Antihypertensive Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Dipine Antihypertensive Drugs Sales Market Share by Country (2020-2031)
Figure 24. North America Dipine Antihypertensive Drugs Revenue Market Share by Country (2020-2031)
Figure 25. United States Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Dipine Antihypertensive Drugs Sales Market Share by Country (2020-2031)
Figure 28. Europe Dipine Antihypertensive Drugs Revenue Market Share by Country (2020-2031)
Figure 29. Germany Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Dipine Antihypertensive Drugs Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Dipine Antihypertensive Drugs Revenue Market Share by Region (2020-2031)
Figure 36. China Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Dipine Antihypertensive Drugs Sales Market Share by Country (2020-2031)
Figure 46. Latin America Dipine Antihypertensive Drugs Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Dipine Antihypertensive Drugs Sales Market Share by Country (2020-2031)
Figure 51. Middle East & Africa Dipine Antihypertensive Drugs Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Dipine Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Dipine Antihypertensive Drugs by Type (2020-2031)
Figure 56. Global Revenue Market Share of Dipine Antihypertensive Drugs by Type (2020-2031)
Figure 57. Global Dipine Antihypertensive Drugs Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Dipine Antihypertensive Drugs by Application (2020-2031)
Figure 59. Global Revenue Market Share of Dipine Antihypertensive Drugs by Application (2020-2031)
Figure 60. Global Dipine Antihypertensive Drugs Price (US$/Unit) by Application (2020-2031)
Figure 61. Dipine Antihypertensive Drugs Value Chain
Figure 62. Dipine Antihypertensive Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

※参考情報

ジピン系降圧剤は、主に高血圧の治療に利用される薬剤であり、ジヒドロピリジン系カルシウムチャネルブロッカーに分類されます。これらの薬剤は、血管の平滑筋を弛緩させることによって血圧を低下させる作用を持っています。主に外周血管に作用し、心臓自体に対してはあまり影響を及ぼさないのが特徴です。

ジピン系降圧剤の主な作用メカニズムは、血管平滑筋の細胞膜に存在するカルシウムチャネルを阻害することです。カルシウムチャネルが開くと、カルシウムイオンが細胞内に流入し、平滑筋が収縮します。この収縮が血管を狭くし、結果的に血圧が上昇しますが、ジピン系降圧剤はこのプロセスを抑制するため、血管が拡張し、血圧が下がります。

ジピン系降圧剤には、いくつかの種類があり、その中でも代表的なものにはアムロジピン、ニフェジピン、フェロジピンなどがあります。これらの薬剤は、効果の持続時間や副作用のプロファイルが異なるため、患者の状況に応じて適切な薬剤が選択される必要があります。アムロジピンは長時間作用型で、1日1回の投与で済むため、患者のアドヒアランスが高くなる傾向があります。一方、ニフェジピンは速効性が特徴であり、急激な高血圧の治療に用いられることがあります。どのジピン系降圧剤を選択するかは、患者の年齢、併存疾患、他の薬剤との相互作用などを考慮して慎重に判断されます。

これらの薬剤は、単独での使用にとどまらず、他の降圧剤や心血管系に作用する薬剤と併用されることがよくあります。例えば、ACE阻害剤やARBs（アンジオテンシンII受容体拮抗薬）との組み合わせでは、相乗効果を生むことが期待できます。また、ジピン系降圧剤は、喘息や慢性閉塞性肺疾患（COPD）がある患者においても比較的安全に使用できることが多いです。

使用にあたっては、副作用に注意する必要があります。ジピン系降圧剤の一般的な副作用には、むくみ（浮腫）、頻脈、頭痛、めまいなどがあります。特にむくみは、下肢や顔面に見られることがあり、予防策として利尿薬の併用が考慮されることもあります。また、稀に心不全の悪化や、重篤なアレルギー反応が報告されることもあるため、使用中に何らかの異常を感じた場合は速やかに医療機関を受診することが求められます。

関連技術としては、バイオマーカーの研究や、患者の血圧変動をリアルタイムでモニタリングするデバイスが進展してきています。これにより、患者個々の状態に応じた個別化医療が推進され、高血圧治療の精度が向上しています。将来的には、ジピン系降圧剤の作用をより一層効果的に活用できる新たな治療法や薬剤が開発される可能性があります。高血圧は心血管疾患のリスク因子であるため、適切な管理が求められるテーマであり、そのための技術革新が期待されています。

さらに、ジピン系降圧剤の効果だけでなく、生活習慣の改善も重要です。適度な運動、健康的な食事、ストレス管理などが血圧のコントロールに寄与します。これらの生活習慣の改善と薬物療法を組み合わせることで、より良い治療結果を得られる可能性が高まります。

総じて、ジピン系降圧剤は高血圧の管理において重要な役割を果たす薬剤であり、様々な種類が存在します。それぞれの薬剤の特性を理解し、適切に患者に応じた治療が行われることが、結果として患者のQOL（生活の質）の向上につながります。最新の研究成果や技術がさらにこれらの治療法を進化させていくことが期待される中で、医療従事者は常に新しい知見を取り入れながら適切な治療を選択していく責任があります。患者自身も治療のプロセスにより積極的に関与し、自己管理を行うことが大切です。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ファモチジン医薬品の世界市場2025年：錠剤、注射剤、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8740 )"ジピン系降圧剤の世界市場2025年：ニフェジピン、アムロジピンベシル酸塩、フェリジピン、ベニジピン、その他" (英文：Global Dipine Antihypertensive Drugs Market Research Report 2025)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。